Literature DB >> 20002657

Liver transplantation from donation after cardiac death donors: initial Belgian experience 2003-2007.

Olivier Detry1, Vincent Donckier, Valerio Lucidi, Dirk Ysebaert, Thiery Chapelle, Jan Lerut, Olga Ciccarelli, Jacques Pirenne, Diethard Monbaliu, Arnaud De Roover, Pierre Honoré, Xavier Rogiers, Bernard De Hemptinne, Roberto Troisi.   

Abstract

The Belgian experience with donation after cardiac death (DCD) liver transplantation (LT) was retrospectively reviewed, particularly evaluating patient and graft survivals, and biliary complications. From 2003 to 2007, 58 DCD-LT were performed in Belgium. Mean procurement total warm ischemia time was 25 +/- 2 min (mean +/- SEM). Mean cold ischemia time was 451 +/- 18 min. Mean follow-up was 23 +/- 2.2 months. Post-transplant peak aspartate aminotransminases was 2241 +/- 338 UI/l. Patient survivals at 1 month, 1 and 3 years, were 91.3%, 83.3% and 66.9% respectively. Graft survivals at 1 month, 1 and 3 years, were 84.4%, 72.4% and 48.8% respectively. Two patients (3.4%) developed primary nonfunction. Regarding the biliary complications, seven grafts (12%) were lost because of intrahepatic cholangiopathy, and 12 other patients (20.6%) developed bile duct stenoses requiring endoscopic and/or surgical management. The rate of symptomatic ischemic biliary lesions for grafts surviving more than 3 months was 38% (19/50). Although DCD organ donors may be a source of viable liver grafts, results were inferior to those obtained with donation after brain death LT in this series. Prognostic criteria have to be developed to improve results of DCD-LT.

Entities:  

Mesh:

Year:  2009        PMID: 20002657     DOI: 10.1111/j.1432-2277.2009.01029.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  8 in total

Review 1.  Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation.

Authors:  Seth J Karp; Scott Johnson; Amy Evenson; Michael P Curry; Diarmuid Manning; Raza Malik; Gerond Lake-Bakaar; Michelle Lai; Douglas Hanto
Journal:  HPB (Oxford)       Date:  2011-04-04       Impact factor: 3.647

2.  Donation after cardio-circulatory death liver transplantation.

Authors:  Hieu Le Dinh; Arnaud de Roover; Abdour Kaba; Séverine Lauwick; Jean Joris; Jean Delwaide; Pierre Honoré; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

3.  Clinical outcomes and quality of life in recipients of livers donated after cardiac death.

Authors:  Neehar D Parikh; Anton I Skaro; Daniela P Ladner; Vadim Lyuksemburg; Joshua G Cahan; Amna Daud; Zeeshan Butt
Journal:  Gastroenterol Res Pract       Date:  2015-04-01       Impact factor: 2.260

4.  Long-term results after transplantation of pediatric liver grafts from donation after circulatory death donors.

Authors:  Rianne van Rijn; Pieter E R Hoogland; Frank Lehner; Ernest L W van Heurn; Robert J Porte
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

5.  Hypothermic oxygenated machine perfusion reduces bile duct reperfusion injury after transplantation of donation after circulatory death livers.

Authors:  Rianne van Rijn; Otto B van Leeuwen; Alix P M Matton; Laura C Burlage; Janneke Wiersema-Buist; Marius C van den Heuvel; Ruben H J de Kleine; Marieke T de Boer; Annette S H Gouw; Robert J Porte
Journal:  Liver Transpl       Date:  2018-04-06       Impact factor: 5.799

6.  Functional Implications of Biochemical and Molecular Characteristics of Donation After Circulatory Death Livers.

Authors:  Ryota Masuzaki; Hui Yu; Philip Kingsley; Lawrence Marnett; Zhongming Zhao; Seth J Karp
Journal:  Transplant Direct       Date:  2015-06-15

7.  Orthotopic liver transplantation from cardiac death donors in the mouse: a new model and evaluation of cardiac death time.

Authors:  Zhenzhen Liu; Ning Pan; Xiangwei Lv; Song Li; Liming Wang; Qinlong Liu
Journal:  Iran J Basic Med Sci       Date:  2017-06       Impact factor: 2.699

8.  The Role of GLP1 in Rat Steatotic and Non-Steatotic Liver Transplantation from Cardiocirculatory Death Donors.

Authors:  Cindy G Avalos-de León; Mónica B Jiménez-Castro; María Eugenia Cornide-Petronio; Araní Casillas-Ramírez; Carmen Peralta
Journal:  Cells       Date:  2019-12-09       Impact factor: 6.600

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.